Connor, Clark & Lunn Investment Management (CC&L)
NVCR icon

Connor, Clark & Lunn Investment Management (CC&L)’s NovoCure NVCR Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10M Sell
661,280
-55,259
-8% -$836K 0.02% 536
2026
Q1 		$7.81M Buy
716,539
+55,242
+8% +$690K 0.02% 546
2025
Q4 		$8.55M Buy
661,297
+96,794
+17% +$1.24M 0.02% 501
2025
Q3 		$7.29M Sell
564,503
-46,211
-8% -$617K 0.02% 483
2025
Q2 		$10.9M Buy
610,714
+75,965
+14% +$1.32M 0.04% 378
2025
Q1 		$9.53M Buy
534,749
+96,977
+22% +$2.2M 0.04% 325
2024
Q4 		$13M Buy
437,772
+11,509
+3% +$244K 0.06% 258
2024
Q3 		$6.66M Buy
426,263
+59,608
+16% +$1.08M 0.03% 373
2024
Q2 		$6.28M Buy
366,655
+52,278
+17% +$919K 0.03% 376
2024
Q1 		$4.91M Sell
314,377
-95,223
-23% -$1.4M 0.02% 434
2023
Q4 		$6.12M Buy
409,600
+761
+0.2% +$10.2K 0.03% 369
2023
Q3 		$6.6M Buy
408,839
+339,610
+491% +$9.79M 0.03% 329
2023
Q2 		$2.87M Buy
69,229
+59,978
+648% +$3.72M 0.01% 510
2023
Q1 		$556K Buy
+9,251
New +$739K ﹤0.01% 856
2022
Q3 		– Sell
-12,750
Closed -$886K – 1210
2022
Q2 		$886K Buy
+12,750
New +$960K 0.01% 648

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s NVCR Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) reduced its NovoCure (NVCR) stake by 7.7% in Q2 2026, selling an estimated $836K and leaving 661,280 shares worth $10M. The position accounts for 0.02% of the portfolio, ranked #536.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in NVCR in Q2 2022 and has held it in 15 quarters since. The position peaked at $13M in Q4 2024. 216 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 661,280 shares of NovoCure worth $10M as of Q2 2026.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 55,259 NovoCure shares in Q2 2026, an estimated $836K.
  • NovoCure made up 0.02% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #536 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in NovoCure in Q2 2022 and has held it in 15 quarters since.
  • Connor, Clark & Lunn Investment Management (CC&L)'s NovoCure position peaked at $13M in Q4 2024.
  • 216 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.